Kangstem Biotech Co. Ltd (KQ:217730) — Market Cap & Net Worth

$135.45 Million USD · ₩199.87 Billion KRW · Rank #18131

Market Cap & Net Worth: Kangstem Biotech Co. Ltd (217730)

Kangstem Biotech Co. Ltd (KQ:217730) has a market capitalization of $135.45 Million (₩199.87 Billion) as of September 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18131 globally and #793 in its home market, demonstrating a -3.85% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kangstem Biotech Co. Ltd's stock price ₩2125.00 by its total outstanding shares 94054149 (94.05 Million). Also see 217730 current and non-current assets for a full breakdown of the balance sheet.

Kangstem Biotech Co. Ltd Market Cap History: 2015 to 2026

Kangstem Biotech Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $522.84 Million to $135.45 Million (-10.55% CAGR). Also see 217730 cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

Kangstem Biotech Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$235.78 Billion	0.06%	#297 of 1384
Kosdaq Composite Index KQ11	$235.78 Billion	0.06%	#297 of 1384

Weight: Kangstem Biotech Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Kangstem Biotech Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Kangstem Biotech Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Kangstem Biotech Co. Ltd for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.04x

Kangstem Biotech Co. Ltd's market cap is 0.04 times its annual revenue

Industry average: 3828.66x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$518.05 Million	$842.80 Million	-$8.30 Billion	0.61x	N/A
2017	$599.59 Million	$9.13 Billion	-$15.42 Billion	0.07x	N/A
2018	$1.11 Billion	$9.17 Billion	-$13.65 Billion	0.12x	N/A
2019	$414.11 Million	$6.00 Billion	-$24.63 Billion	0.07x	N/A
2020	$402.41 Million	$9.14 Billion	-$18.47 Billion	0.04x	N/A
2021	$189.93 Million	$12.40 Billion	-$21.35 Billion	0.02x	N/A
2022	$168.15 Million	$16.30 Billion	-$20.24 Billion	0.01x	N/A
2023	$152.66 Million	$5.91 Billion	-$21.95 Billion	0.03x	N/A
2024	$128.75 Million	$7.75 Billion	-$7.67 Billion	0.02x	N/A
2025	$147.87 Million	$3.57 Billion	-$10.48 Billion	0.04x	N/A

Competitor Companies of 217730 by Market Capitalization

Companies near Kangstem Biotech Co. Ltd in the global market cap rankings as of September 19, 2026. Review Kangstem Biotech Co. Ltd tangible equity quality to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Kangstem Biotech Co. Ltd by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $128.84 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #340 globally with a market cap of $79.38 Billion USD.
CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $60.28 Billion USD ( AU$85.19 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#189	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$128.84 Billion	$508.34
#340	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$79.38 Billion	$784.85
#459	CSL Ltd	AU:CSL	$60.28 Billion	AU$175.59
#505	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$154.04

Kangstem Biotech Co. Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Kangstem Biotech Co. Ltd's market cap moved from $522.84 Million to $ 135.45 Million, with a yearly change of -10.55%.

Year	Market Cap	Change (%)
2026	₩135.45 Million	-8.41%
2025	₩147.87 Million	+14.85%
2024	₩128.75 Million	-15.66%
2023	₩152.66 Million	-9.21%
2022	₩168.15 Million	-11.47%
2021	₩189.93 Million	-52.80%
2020	₩402.41 Million	-2.83%
2019	₩414.11 Million	-62.66%
2018	₩1.11 Billion	+84.97%
2017	₩599.59 Million	+15.74%
2016	₩518.05 Million	-0.92%
2015	₩522.84 Million	--

End of Day Market Cap According to Different Sources

On Sep 19th, 2026 the market cap of Kangstem Biotech Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$135.45 Million USD
MoneyControl	$135.45 Million USD
MarketWatch	$135.45 Million USD
marketcap.company	$135.45 Million USD
Reuters	$135.45 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$135.45 Million

₩199.87 Billion KRW

Market Cap Rank

#18131 Global

#793 in Korea

Share Price

₩2125.00

Change (1 day)

-0.70%

52-Week Range

₩1397.00 - ₩4615.00

All Time High

₩18836.30